Chatenay Malabry, France

Christophe Philippe Moinet

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Chatenay Malabry, FR (2003 - 2007)
  • Montréal, CA (2009)

Company Filing History:


Years Active: 2003-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Christophe Philippe Moinet: A Patent Trail

Introduction: Christophe Philippe Moinet, a distinguished inventor residing in Chatenay Malabry, France, has made significant contributions to the field of pharmaceuticals with his inventive prowess. With a total of four patents to his name, Moinet focuses primarily on the development of imidazolyl derivatives, which hold promise in the realm of somatostatin receptor research.

Latest Patents: Moinet's recent innovations include the formulation of imidazolyl derivatives, specifically designed as agonists or antagonists of somatostatin receptors. The first patent delineates imidazolyl derivatives of a specific formula (I), wherein detailed substituents are specified, showcasing their potential therapeutic applications. The second patent reiterates the significance of these imidazolyl derivatives and their pharmaceutically acceptable salts, once again emphasizing their utility in modulating somatostatin receptors, adhering closely to the same defined formula (I) and stipulations outlined in the description.

Career Highlights: Moinet has had the opportunity to collaborate with multiple reputable organizations throughout his career. Notably, he has worked with the Société De Conseils De Recherches Et D'applications Scientifiques, S.A.S., a company known for its commitment to scientific research and applications. His work in these institutions underscores his dedication to advancing pharmaceutical innovations.

Collaborations: Throughout his career, Moinet has collaborated with esteemed professionals, notably Christophe Thurieau and Lydie Francine Poitout. These partnerships have undoubtedly enriched his research endeavors and contributed to the successful development of his patented inventions.

Conclusion: Christophe Philippe Moinet stands as a prominent figure in pharmaceutical innovation. His dedication to exploring the potential of imidazolyl derivatives and their applications in somatostatin receptor modulation highlights his significant role as an inventor. With his ongoing contributions to the field, Moinet continues to inspire innovation and progress in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…